HCA250117C250000
- 57.50
- 0.000.00%
HCA Healthcare Newsroom
HCA Healthcare Stock Trades at Premium: Time to Buy or Hold?
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Optimistic Outlook and Buy Rating for HCA Healthcare Driven by Strategic Initiatives and Market Dynamics
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
HCA Healthcare Chief Ethics, Compliance Officer Kathi Whalen to Retire
Express News | HCA Healthcare Names Wendy Warren as Senior Vice President and Chief Ethics and Compliance Officer
U.S. Healthcare Spending Climbs 7.5% in 2023
HCA Healthcare, Inc. (NYSE:HCA) Shares Could Be 45% Below Their Intrinsic Value Estimate
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Fed FOMC Preview: Hawkish Powell Poised to Signal Rate Cuts Are Over
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today
HCA Healthcare Price Target Cut to $355.00/Share From $406.00 by Morgan Stanley
HCA Healthcare Is Maintained at Equal-Weight by Morgan Stanley
Goldman Sachs Maintains HCA Healthcare(HCA.US) With Hold Rating, Cuts Target Price to $319
Tuesday Tech Pull Back After Nasdaq and Bitcoin Record | Live Stock
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Ondine Biomedical to Start Late-stage Trial for Nasal Photodisinfection Technology
Morgan Stanley Maintains HCA Healthcare(HCA.US) With Hold Rating, Cuts Target Price to $355